Eva Medtec, Inc

Shakopee, MN · Founded 2012 · Medtech · Private

Neuroglide, an FDA-cleared automated therapeutic system for targeted pain relief and circulation improvement via non-invasive delivery

Claim this profile

Follows are private to you and power your alerts

Updated · neuroglide.com

Sector
Medtech
Headquarters
Shakopee, MN
Founded
2012
Latest Form D
$50K, May 2025
Total capital
$872K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$872K
9 Form D · last May 2025
18 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
4
1 pending · first 2021
Rank in peer group#337 of 1112

Capital timeline

201520172019202120232025FEDERAL ↑EQUITY ↓Cumulative $872K2nd Form D$100K7th Form D$80K
201520172019202120232025FEDERAL ↑EQUITY ↓Cumulative $872K

Latest events

  • Private capital raisedForm D · SEC · 9th filing$50K
  • Private capital raisedForm D · SEC · 8th filing$50K
  • Private capital raisedForm D · SEC · 7th filing$80K
  • Private capital raisedForm D · SEC · 6th filing$25K
  • Private capital raisedForm D · SEC · 5th filing$32K
  • Private capital raisedForm D · SEC · 4th filing$480K
  • Private capital raisedForm D · SEC · 3rd filing$35K
  • Private capital raisedForm D · SEC · 2nd filing$100K
  • Private capital raisedForm D · SEC · 1st filing$20K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#337 · top 30%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Irene WaldridgeResearcherExecutive OfficerLinked by 4 patents
  • Barry JohnsonExecutive OfficerNamed in SEC Form D filings
  • David RuppExecutive Officer, DirectorNamed in SEC Form D filings
  • HIEU LEExecutive OfficerNamed in SEC Form D filings
  • John DinussonExecutive Officer, DirectorNamed in SEC Form D filings
  • Tim KoepplExecutive OfficerNamed in SEC Form D filings
Show all 8 people
  • Toni HastingsExecutive OfficerNamed in SEC Form D filings
  • Wieden RobertExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 4 granted of 5
Show all 5 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .